altRX Review

altRX: the one platform that carries all four brand-name GLP-1s

Most telehealth weight-loss companies make you pick a lane: either they sell low-cost compounded medication, or they write prescriptions for the brand-name pens and hand you off to a pharmacy. altRX is the rare provider that does both under one roof — and on the brand-name side it goes further than anyone else we've reviewed. It's the only platform in our directory that offers all four FDA-approved GLP-1s — Mounjaro, Ozempic, Wegovy, and Zepbound — alongside its own compounded semaglutide and tirzepatide. If you already know which branded pen you want, or you want the freedom to start cheap on compounded and switch to brand later, altRX is built for exactly that. The catch is that several things a cautious shopper would want to confirm — which states it serves, which pharmacy fills the compounded vials — aren't spelled out publicly.

How the six-tier pricing actually works

altRX runs a flat, all-inclusive model rather than a membership. There's no monthly platform fee stacked on top of your medication, and the company states plainly that the price you see covers the consult, the prescription process, and shipping. That matters, because plenty of competitors quote a low medication number and then bolt on a separate consult fee at checkout. Here there's one number per product.

• Compounded semaglutide opens the ladder at $149 a month — the figure altRX advertises as its starting tier and the cheapest way onto the platform.
• Compounded tirzepatide (the GLP-1/GIP dual agonist) starts a bit higher, reflecting the more complex molecule.
• The four brand-name pens — Ozempic, Mounjaro, Zepbound, and Wegovy — all sit north of a thousand dollars a month, cash-pay, which is roughly in line with U.S. retail list prices.

For context, the compounded starting price sits below our category median of $170, so on the compounded side altRX is competitively, not aggressively, priced. The brand-name tiers are a different story: paying full cash for a branded GLP-1 anywhere is expensive, and altRX doesn't pretend otherwise. New patients are offered an intro discount and free shipping on a first order, but the company doesn't run a permanent teaser rate, so budget around the standard prices above.

What sets altRX apart: real brand-name access

The genuine differentiator here isn't the compounded product — dozens of providers sell that. It's that altRX will actually prescribe and arrange the real, FDA-approved pens. If you've been on Zepbound and don't want to switch to a compounded version, or your clinician specifically wants you on Mounjaro, most compounding-first telehealth shops simply can't help. altRX can. Having compounded and brand under the same login also makes it painless to start on the affordable compounded tier and graduate to a branded pen later without re-registering somewhere new. That flexibility is the core reason to choose this platform over a single-modality competitor.

Medications and how they're dispensed

On the brand side, altRX prescribes the standard FDA-approved injectables and they're filled through normal pharmacy channels. On the compounded side, the company says its GLP-1s are produced in FDA-regulated facilities through 'multiple USA-certified pharmacies.' altRX also publishes the FDA's compounded-medication disclaimer prominently — that compounded drugs are not approved or evaluated for safety, effectiveness, or quality by the FDA, and require a prescription. We treat that transparency as a positive: a provider that surfaces the disclaimer rather than burying it is being straight with you. That said, altRX does not name the specific pharmacy partner, nor does it state whether the compounding is done at a 503A (patient-specific) or 503B (outsourcing facility) pharmacy — a distinction safety-conscious patients increasingly ask about.

Trust, oversight, and where the gaps are

altRX carries a verifiable LegitScript certification (ID 48475686), which you can check independently — a meaningful credential that screens out a lot of fly-by-night sellers. Its corporate structure is also disclosed, if unusual: the platform operates through 'CareGLP Affiliated P.C.s' (professional corporations) paired with a telemedicine network called CareValidate Health, a network of U.S.-licensed physicians. The affiliated-P.C. framing suggests a state-by-state professional-corporation setup rather than one national entity, which is common in telehealth but worth understanding.

Here's where we hold altRX to a medium confidence rating rather than high. The company does not publish its list of states served, so you'll need to confirm coverage before you get attached. It names no medical director, discloses no corporate physical address, and — as noted — doesn't identify its compounding pharmacy or its 503A/503B designation. None of these are red flags on their own, but together they're the difference between 'verified and complete' and 'verified with open questions.' See our scoring methodology for how we weigh these signals.

Who should choose altRX, and who should skip it

• Choose it if you specifically want a brand-name pen (Ozempic, Mounjaro, Wegovy, or Zepbound) by cash-pay and value having compounded options in the same place.
• Choose it if you want one all-inclusive price with no membership fee and fast turnaround — altRX advertises approval in as little as one day, quicker than the typical 24–72 hour wait.
• Skip it (or at least price-check first) if you have commercial insurance that might cover a branded GLP-1 — altRX's brand pricing is cash-pay, and your copay through coverage could be far lower.
• Skip it if you need to confirm your state is served before committing, or if a named medical director and an identified pharmacy partner are non-negotiable for you.

The bottom line

altRX earns its place for one clear reason: nobody else in our directory lets you get all four brand-name GLP-1s and compounded versions from a single, LegitScript-certified platform with one all-inclusive price. The compounded starting tier is reasonable, the brand-name access is genuinely unique, and the pricing is refreshingly free of hidden fees. The reservations are about disclosure, not conduct — undisclosed states, an unnamed pharmacy, and no listed medical director keep it short of a top-tier trust score. If brand-name flexibility is what you're after and you're paying cash, altRX is worth a serious look; just confirm your state and your pharmacy details before you order.

For a side-by-side, Yucca Health ($146/month) and DudeMeds ($149/month) are the most comparable options to weigh against altRX.